Andrew S.C. Rice MB BS, MD, FRCP, FRCA, FFPMRCA, FFPMCAI is Professor of Pain Research at Imperial College London, where he is engaged in translational research and clinical practice in neuropathic pain. He received his medical degree from St. Mary’s Hospital Medical School in 1982 and his research doctorate from St. Thomas’ Hospital Medical School in 1991. He underwent specialist training in Oxford and at St Thomas’ Hospital and joined the academic staff of Imperial College in 1995.
His research covers both laboratory and clinical aspects, with emphasis on neuropathic pain in the context of infectious disease (HIV, leprosy, HTLV-1 and herpes zoster), diabetes and peripheral nerve trauma – activities range from animal models, through deep profiling of patients with a view to personalised medicine to clinical trials and evidence synthesis. He also works in improving the external and internal validities of animal models and the medical history of neuropathic pain, especially that arising from 20th century conflicts. His research has been funded predominantly by the Wellcome Trust and European Commission.
He is an author of more than 160 peer reviewed scientific publications, many of which are in the major specialist journal in the field (PAIN). He has also published in other notable journals including: The Lancet, Brain, Lancet Neurology, New England Journal of Medicine and the British Medical Journal. His work has a citation (Hirsch) index of 48. He conceived and was lead editor of the four volume “Textbook of Clinical Pain Management”. He is Editor in Chief of the IASP publication Pain: Clinical Updates and serves on the editorial boards of several journals.
In 2016 Andrew was elected as a Councillor of the International Association for the Study of Pain. He is the IASP liaison to the Association of South-East Asian Pain Societies (ASEAPS) and Chair of the Scientific Programme Committee for the 18th World Congress on Pain (2020). He has also held a number of leadership positions within the IASP Special Interest Group on Neuropathic Pain (NeuPSIG) and was Chair 2012-14. He was a Principal Investigator of the Wellcome Trust funded London Pain Consortium of which he was Administrative Director 2008-12. He was the academic lead for animal model innovation in the EU Innovative Medicines Initiative “EUROPAIN.
In 2017 Andrew was awarded the Rynd medal by the Faculty of Pain Medicine, College of Anaesthetists of Ireland. In 2015, he delivered the Patrick Wall Lectures at the British Pain Society and at the Faculty of Pain Medicine, Royal College of Anaesthetists. Also in 2015, he received the Imperial College Lifetime Achievement Award for Excellence in Animal Research. He was the Michael Cousins lecturer at the Australian and New Zealand College of Anaesthetists in 2009 and Covino Lecturer at Harvard University in 2008.
Andrew is an Honorary Consultant in Pain Medicine at the Chelsea and Westminster Hospital, London. As a member of a comprehensive multi-disciplinary pain management team, he provides a diagnostic and treatment service for patients with neuropathic pain; in particular peripheral nerve injury and infectious disease (mainly postherpetic neuralgia, leprosy and HIV). With Palliative and Addiction Medicine colleagues, he has established a review clinic for patients on inappropriately high doses of prescription opioids. He has developed an assessment pathway for military patients with neuropathic pain following Non Freezing Cold Injury.